Ninfa Saunders - 25 Jun 2022 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role
Director
Signature
/s/ John Sprague, Attorney-in-Fact
Issuer symbol
TTOO
Transactions as of
25 Jun 2022
Transactions value $
$0
Form type
4
Filing time
28 Jun 2022, 17:22:22 UTC
Previous filing
04 Jan 2022
Next filing
09 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTOO Common Stock Options Exercise +73,224 +1.33% 128,209 25 Jun 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTOO Restricted Stock Units Options Exercise $0 -73,224 -100% $0* 0 25 Jun 2022 Common Stock 73,224 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 On June 25, 2021, the reporting person was granted 73,224 restricted stock units that vested on the earlier of (i) June 25, 2022, and (ii) the date of the next annual meeting of stockholders.